Evidence map›Paper›PMID 42661990›Full record

ArticleBrain communications2026

NOR1 loss relates to inflammation and biological ageing in multiple sclerosis motor cortex.

Buse Unlu Kobya, Aimee Avery, Gabriele DeLuca, Jonathan Pansieri

Abstract read
In one paragraph

Article in Brain communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Buse Unlu KobyaNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Aimee AveryNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Gabriele DeLucaNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Jonathan PansieriNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Oxfordshire, United Kingdom.ORCID https://orcid.org/0000-0001-8918-9943

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cortical neurodegeneration and glial activation are major drivers of disability progression in multiple sclerosis, but the molecular mechanisms underlying these processes remain poorly defined. Members of the NR4A nuclear receptor family are stress-responsive transcription factors that regulate neuronal survival, inflammatory signalling and cellular adaptation to metabolic and oxidative stress. In particular, neuron-derived orphan receptor 1 (NR4A3) has been implicated in neuroprotective and stress-adaptive responses in other neurological conditions, but its role in multiple sclerosis has not been investigated. Given its dual involvement in neuronal stress regulation and inflammatory modulation, neuron-derived orphan receptor 1 represents a plausible molecular link between chronic neuroinflammation, biological ageing and cortical neurodegeneration in multiple sclerosis. Here, we examined neuron-derived orphan receptor 1 expression in the motor cortex of post-mortem multiple sclerosis (

Indexed as

ageinginflammationmultiple sclerosisNR4A3

Identifiers

PMID42661990
PMCPMC13519354

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.